- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05433259
Biometric Factors Changes Caused by Myopia Orthokeratology (OK) Lens
June 25, 2022 updated by: Yune Zhao, Wenzhou Medical University
The Influence on Biometric Factors Changes by Different OK Lens
Subjects fit with VST or CRT type lens are reviewed 1 day to 2 year after first wearing the lens.
Ocular examinations were performed, including slit-lamp biomicroscope, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography (Medmont E300W, Medmont Pty Ltd, Melbourne, Australia), corneal refractive power (autorefractometer, KR880, Topcon, JAPAN), corneal epithelial thickness (Optical Coherence Tomography, RTVue-XR), axial length using IOL-Master 700 (Carl Zeiss Meditec AG).
To investigate corneal and retina changes caused by overnight OK lens.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Zhejiang
-
Wenzhou, Zhejiang, China
- Eye Hospital of Wenzhou Medical College
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Normal subjects without any history of ocular surgeries or diseases (except for refractive errors) or systemic diseases that might affect contact lens wearing. The spherical error between -1.0 and -5.0 D, cylindrical error of at most 2.0 D, and a corrected distance visual acuity of 20/20 or better.
Exclusion Criteria:
- Subjects who had previously worn contact lens, were also excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CRT type lens
Subjects fitted with CRT type lenses
|
Subjects require to wear the lenses every night, with a recommended time of 6-8 hours.
|
EXPERIMENTAL: VST type lens
Subjects fitted with VST type lenses
|
Subjects require to wear the lenses every night, with a recommended time of 6-8 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
change of Corneal Epithelium
Time Frame: up to 1 day, 1 week,1 month
|
All epithelial thickness and treatment zone area record by baseline and follow up examination.
|
up to 1 day, 1 week,1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Axial length
Time Frame: up to 2 years
|
Axial length growth after lens wear
|
up to 2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2021
Primary Completion (ACTUAL)
March 12, 2022
Study Completion (ANTICIPATED)
November 1, 2023
Study Registration Dates
First Submitted
June 21, 2022
First Submitted That Met QC Criteria
June 21, 2022
First Posted (ACTUAL)
June 27, 2022
Study Record Updates
Last Update Posted (ACTUAL)
June 30, 2022
Last Update Submitted That Met QC Criteria
June 25, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- OK lens-Angio OCT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lenses
-
HOYA Lamphun LtdUnknown
-
Alcon ResearchCompletedContact LensesUnited Kingdom
-
Alcon ResearchCompletedContact LensesUnited Kingdom
-
Hom, Milton M., OD, FAAOBausch & Lomb IncorporatedUnknown
-
University of HoustonUnknown
-
University of Texas Southwestern Medical CenterNational Eye Institute (NEI); CIBA VISIONCompletedContact Lenses, Extended-WearUnited States
-
Bausch & Lomb IncorporatedCompletedMyopia | Contact LensesUnited States
-
University of Texas Southwestern Medical CenterCompletedMyopia | Soft Contact LensesUnited States
-
Sun Yat-sen UniversityUnknownMultifocal Contact LensesChina
-
State University of New York College of OptometryJohnson & Johnson Vision Care, Inc.CompletedAsthenopia | Contact Lenses | Ocular Accommodation | Convergence, ExcessUnited States
Clinical Trials on Overnight orthokeratology
-
Acuity Polymers, Inc.Not yet recruitingMyopiaUnited States, Australia, New Zealand
-
Menicon Co., Ltd.Active, not recruiting
-
Tianjin Eye HospitalRecruiting
-
Art Optical Contact Lens, Inc.University of Missouri, St. LouisNot yet recruiting
-
The Hong Kong Polytechnic UniversityAston University; Queensland University of Technology; Menicon Co., Ltd.Completed
-
Euclid Systems CorporationNot yet recruiting
-
Medical University of ViennaRecruiting
-
Sun Yat-sen UniversityUnknown
-
University of Alabama at BirminghamCompletedDry Eye | Contact Lens ComplicationUnited States
-
Mansoura UniversityRecruiting